Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Monocytopenia Is Universally Present in Adults with Hemophagocytic Syndrome/Hemophagocytic Lymphohistiocytosis (HLH), Responds to Treatment, and Can be Used As a Sensitive Additional Diagnostic Criterion and As a Prognostic Marker

Said Yousuf Mohamed, MD, Muhamad Hitham Almahayni, MD MRCP, Wahiba Chebbo, Ahmed Shad, MRCP, MD, Abdul Mannan, Osama Abdelwahid, Maamoun AlSermani, MRCP, MD, Feras Alfraih, MD, Shaheen Marwan, MD, Majed Halim, MD, Nasir Bakshi, MD, Hazaa Alzahrany

Blood (2016) 128 (22): 1330.

https://doi.org/10.1182/blood.V128.22.1330.1330

Published: 2016

Journal Articles

Addition of ATG to Myeloablative Haplo Conditioning with Post-Transplantation Cyclophosphamide Might Decrease the Risk of Gvhd and TRM without Increasing the Risk of Relapse

Blood (2016) 128 (22): 5871.

https://doi.org/10.1182/blood.V128.22.5871.5871

Published: 2016

Journal Articles

BK Virus-Associated Hemorrhagic Cystitis Following Allogeneic Hematopoietic Stem Cell Transplantation; Incidence and Risk Factors

Feras Alfraih, MD, Amjad Alhussaini, Farhan Anjum, Ghuzayel Mubarak Aldawsari, Fahad Alsharif, MD, Said Y Mohamed, MD, Walid Rasheed, MD, Syed Osman Ahmed, MRCP, FRCPath, Amr Hanbali, MD, Marwan Shaheen, MD, Riad O. El Fakih, MD, Hazza A Alzahrani, MD, Naeem A. Chaudhri, MD FACP, Fahad Almohareb, Mahmoud Aljurf, MD MPH

Blood (2016) 128 (22): 5759.

https://doi.org/10.1182/blood.V128.22.5759.5759

Published: 2016

Journal Articles

Real-World Data Indicates That the Addition of Etoposide to Idarubicin and Cytarabine (3+7) Induction in Young Adults (<60 years) with AML Does Not Improve Survival or Remission Rates

Blood (2016) 128 (22): 4010.

https://doi.org/10.1182/blood.V128.22.4010.4010

Published: 2016

Journal Articles

Influence of Matched Sibling Donor's Availability and Stem Cell Transplantation on Treatment Outcome for Acute Lymphoblastic Leukemia; Study on 294 Patients

Feras Alfraih, MD, Wahiba Chebbo, Dennis Dong Hwan Kim, MD PhD, Ghuzayel Aldawsari, MD, Fahad Z. Alsharif, MBChB, MD, Hazza A Alzahrani, MD, Said Y Mohamed, MD, Walid Rasheed, MD, Amr Hanbali, MD, Syed Osman Ahmed, MRCP, FRCPath, Marwan Shaheen, MD, Naeem A. Chaudhri, MD FACP, Fahad Al Mohareb, MD, Mahmoud Aljurf, MD MPH

Blood (2015) 126 (23): 4387.

https://doi.org/10.1182/blood.V126.23.4387.4387

Published: 2015

Journal Articles

Propensity Score Matching Analysis Demonstrates the Use of Statin Enhances Chance of Achieving MR4.5 in Chronic Myeloid Leukemia Patients in Chronic Phase Following Imatinib Therapy Regardless of Other Clinical Features Including Age of the Patients

Dennis Dong Hwan Kim, MDPhD, Feras Alfraih, MD, Tanya Adityan, Jeffrey H. Lipton, MD PhD

Blood (2015) 126 (23): 4026.

https://doi.org/10.1182/blood.V126.23.4026.4026

Published: 2015

Journal Articles

Young Adult Patients with Post -HCT Relapse of AML May Benefit from Aggressive Salvage and 2 nd Cellular Therapy

Syed Osman Ahmed, MRCP, FRCPath, Amna Gamil, MD, Muhamad Hitham Almahayni, MD MRCP,, Naeem A. Chaudhri, MD FACP, Fahad Alsharif, MD, Said Y Mohamad, MD, Hazza A Alzahrani, MD, Walid Rasheed, MD, Ghuzayel Aldawsari, MD, Amr Hanbali, MD, Marwan Shaheen, MD, Feras Alfraih, MD, Shad Ahmed, MD, Khaled Ibrahim, Fahed Almhareb, MD, Mahmoud Aljurf, MD MPH

Blood (2015) 126 (23): 5482.

https://doi.org/10.1182/blood.V126.23.5482.5482

Published: 2015

Journal Articles

CD20 Expression Is Associated with Higher Risk of Early Relapse at 1 Year Following Chemotherapy Treatment for Adolescent and Adult Acute Lymphoblastic Leukemia Patients

Feras Alfraih, MD, Abdul Mannnan, Dennis Dong Hwan Kim, MD PhD, Ghuzayel Aldawsari, MD, Fahad Z. Alsharif, MBChB, MD, Hazza A Alzahrani, MD, Said Y Mohamed, MD, Walid Rasheed, MD, Amr Hanbali, MD, Syed Osman Ahmed, MRCP, FRCPath, Marwan Shaheen, MD, Fahad Al Mohareb, MD, Mahmoud Aljurf, MD MPH, Naeem A. Chaudhri, MD FACP

Blood (2015) 126 (23): 3728.

https://doi.org/10.1182/blood.V126.23.3728.3728

Published: 2015

Journal Articles

Fertility Recovery Following Allogeneic Bone Marrow Transplantation in Aplastic Anemia; A Study of 157 Patients

Feras Alfraih, MD, Shad Ahmed, MD, Dennis Dong Hwan Kim, MD PhD, Walid Rasheed, MD, Ghuzayel Aldawsari, MD, Fahad Alsharif, MD, Said Y Mohamed, MD, Amr Hanbali, MD, Syed Osman Ahmed, MRCP, FRCPath, Marwan Shaheen, MD, Naeem A. Chaudhri, MD FACP, Fahad Al Mohareb, MD, Mahmoud Al-Jurf, MD, Hazza A Alzahrani, MD

Blood (2015) 126 (23): 4783.

https://doi.org/10.1182/blood.V126.23.4783.4783

Published: 2015

Journal Articles

Molecular Classification of Bone Marrow Failure Syndromes: Protein Signatures As Surrogate Biomarker for Accurate Diagnosis of Severe Aplastic Anemia, Hypoplastic Myelodysplastic Syndrome and Paroxysmal Nocturnal Hemoglobinuria Patients

Ayodele Alaiya, MPH,MBBS,PhD FRCPath, Hazza A Alzahrani, MD, Zakia Shinwari, MSc, Tarek Owaidah, MD FRCPA, Fahad Al Mohareb, MD, Fahad Al Sharif, MD, Randa Al Nounou, MD, Naeem A. Chaudhri, MD FACP, Ghuzayel Aldawsari, MD, Amr Hanbali, MD, Marwan Shaheen, MD, Feras Alfraih, MD, Syed Osman Ahmed, MD MRCP, FRCPath, Mahmoud Aljurf, MD MPH

Blood (2015) 126 (23): 2414.

https://doi.org/10.1182/blood.V126.23.2414.2414

Published: 2015

Journal Articles

The Use of Statin Enhances Chance of Achieving MR4.5 in Chronic Myeloid Leukemia Patients in Chronic Phase Following Imatinib Therapy

Dennis Dong Hwan Kim, MDPhD, Feras Alfraih, MD, Honggi Lee, MD, Jeffrey H. Lipton, MD PhD

Blood (2014) 124 (21): 1804.

https://doi.org/10.1182/blood.V124.21.1804.1804

Published: 2014

Journal Articles

Multiple CMV Reactivations Are Associated with Lower Risk of Relapse Following Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation

Feras Alfraih, MD, Naheed Alam, MBBS,MD, Vikas Gupta, MD FRCP, FRCPath, Dennis Dong Hwan Kim, MDPhD, John Kuruvilla, MD, Jeffrey H. Lipton, MD PhD, David Loach, MD, Matthew D. Seftel, MRCP, FRCPC, MPH, Jieun Uhm, MD, Anna Lambie, NP, Hans A. Messner, PhD

Blood (2014) 124 (21): 3955.

https://doi.org/10.1182/blood.V124.21.3955.3955

Published: 2014

Journal Articles

HCT-CI Has Prognostic Value in Acute, but Not Chronic Gvhd Specific Survival

Marc Poch Martell, MD, Nada Hamad, MBBS Hons, FRACP, FRCPA, Fotios V. Michelis, MDPhD, Jieun Uhm, MD, Feras Alfraih, MD, Mohamed Shanavas, MD FRACP, FRCPA, Vikas Gupta, MD FRCP, FRCPath, John Kuruvilla, MD, Jeffrey H. Lipton, MD PhD, Hans A. Messner, MD PhD, Matthew D. Seftel, MRCP, FRCPC, MPH, Dennis Kim, MDPhD

Blood (2014) 124 (21): 3915.

https://doi.org/10.1182/blood.V124.21.3915.3915

Published: 2014

Journal Articles

A Risk Score to Predict CMV Viremia within the First 100 Days after Allogeneic Stem Cell Transplantation Based on Pre-Transplant Parameters

Feras Alfraih, MD, John Kuruvilla, MD, Naheed Alam, MBBS,MD, Anna Lambie, NP, Vikas Gupta, MD FRCP, FRCPath, Dennis Dong Hwan Kim, MDPhD, Matthew D. Seftel, MRCP, FRCPC, MPH, Jieun Uhm, MD, David Loach, MD, Eshetu G Atenafu, M.Sc., Jeffrey H. Lipton, MD PhD, Hans A. Messner, MD PhD

Blood (2014) 124 (21): 3877.

https://doi.org/10.1182/blood.V124.21.3877.3877

Published: 2014

Journal Articles

Clinical Characteristics, Risk Factors and Outcomes of CMV Disease after Allogeneic Stem Cell Transplantation

Feras Alfraih, MD, Naheed Alam, MBBS,MD, Anna Lambie, NP, Vikas Gupta, MD FRCP, FRCPath, Dennis Dong Hwan Kim, MDPhD, John Kuruvilla, MD, Jeffrey H. Lipton, MD PhD, Matthew D. Seftel, MRCP, FRCPC, MPH, Jieun Uhm, MD, David Loach, MD, Hans A. Messner, MD PhD

Blood (2014) 124 (21): 3879.

https://doi.org/10.1182/blood.V124.21.3879.3879

Published: 2014

Journal Articles

Serum Albumin Level < 32 g/l on Day 30 Can Predicts Higher Risk of Non-Relapse Mortality in Acute Lymphoblastic Leukemia Following Allogeneic Stem Cell Transplantation

Feras Alfraih, MD, Vikas Gupta, MD FRCP, FRCPath, John Kuruvilla, MD, Jeffrey H. Lipton, MD PhD, Hans A. Messner, MD PhD, Matthew D. Seftel, MRCP, FRCPC, MPH, Jieun Uhm, MD, Dennis Dong Hwan Kim, MD PhD

Blood (2014) 124 (21): 5930.

https://doi.org/10.1182/blood.V124.21.5930.5930

Published: 2014

Journal Articles

Expression Proteomics As Surrogate Biomarkers For Early Treatment Response In Chronic Myeloid Leukemia (CML) Patients

Ayodele Alaiya, MD, MPH, PhD, Naeem Chaudhri, MD, Tarek Owaidah, MD, FRCPA, Jonathan Fox, PhD, Zakia Shinwari, MSc, Eman Barhoush, BSc, Fahad Alsharif, MD, Said Y Mohamed, MD, Walid Rasheed, M.D., Feras Alfraih, MD, Mahmoud Aljurf, M.D.

Blood (2013) 122 (21): 4016.

https://doi.org/10.1182/blood.V122.21.4016.4016

Published: 2013

Journal Articles

CMV Reactivations and Their Impact On Outcomes in Patients After Hematopoietic Cell Transplantation

Naheed Alam, MBBS, Anna Lambie, NP, Yvette Neme Yunes, MD, Feras Alfraih, MD, Eshetu G Atenafu, MSc, Dennis Dong Hwan Kim, MD, PhD, Vikas Gupta, MD, FRCP, FRCPath, John Kuruvilla, MD, Jeff H Lipton, MD, Hans A. Messner, M.D./Ph.D

Blood (2012) 120 (21): 4501.

https://doi.org/10.1182/blood.V120.21.4501.4501

Published: 2012

NARROW

Monocytopenia Is Universally Present in Adults with Hemophagocytic Syndrome/Hemophagocytic Lymphohistiocytosis (HLH), Responds to Treatment, and Can be Used As a Sensitive Additional Diagnostic Criterion and As a Prognostic Marker

Addition of ATG to Myeloablative Haplo Conditioning with Post-Transplantation Cyclophosphamide Might Decrease the Risk of Gvhd and TRM without Increasing the Risk of Relapse

BK Virus-Associated Hemorrhagic Cystitis Following Allogeneic Hematopoietic Stem Cell Transplantation; Incidence and Risk Factors

Real-World Data Indicates That the Addition of Etoposide to Idarubicin and Cytarabine (3+7) Induction in Young Adults (<60 years) with AML Does Not Improve Survival or Remission Rates

Influence of Matched Sibling Donor's Availability and Stem Cell Transplantation on Treatment Outcome for Acute Lymphoblastic Leukemia; Study on 294 Patients

Propensity Score Matching Analysis Demonstrates the Use of Statin Enhances Chance of Achieving MR4.5 in Chronic Myeloid Leukemia Patients in Chronic Phase Following Imatinib Therapy Regardless of Other Clinical Features Including Age of the Patients

Young Adult Patients with Post -HCT Relapse of AML May Benefit from Aggressive Salvage and 2 nd Cellular Therapy

CD20 Expression Is Associated with Higher Risk of Early Relapse at 1 Year Following Chemotherapy Treatment for Adolescent and Adult Acute Lymphoblastic Leukemia Patients

Fertility Recovery Following Allogeneic Bone Marrow Transplantation in Aplastic Anemia; A Study of 157 Patients

Molecular Classification of Bone Marrow Failure Syndromes: Protein Signatures As Surrogate Biomarker for Accurate Diagnosis of Severe Aplastic Anemia, Hypoplastic Myelodysplastic Syndrome and Paroxysmal Nocturnal Hemoglobinuria Patients

The Use of Statin Enhances Chance of Achieving MR4.5 in Chronic Myeloid Leukemia Patients in Chronic Phase Following Imatinib Therapy

Multiple CMV Reactivations Are Associated with Lower Risk of Relapse Following Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation

HCT-CI Has Prognostic Value in Acute, but Not Chronic Gvhd Specific Survival

A Risk Score to Predict CMV Viremia within the First 100 Days after Allogeneic Stem Cell Transplantation Based on Pre-Transplant Parameters

Clinical Characteristics, Risk Factors and Outcomes of CMV Disease after Allogeneic Stem Cell Transplantation

Serum Albumin Level < 32 g/l on Day 30 Can Predicts Higher Risk of Non-Relapse Mortality in Acute Lymphoblastic Leukemia Following Allogeneic Stem Cell Transplantation

Expression Proteomics As Surrogate Biomarkers For Early Treatment Response In Chronic Myeloid Leukemia (CML) Patients

CMV Reactivations and Their Impact On Outcomes in Patients After Hematopoietic Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only